BioPlus Acquisition (BIOS) Stock Forecast for 2023 – 2026. Sell or Buy?
Last update: June 8, 2023 (07:40)
Sector: FinancialThe share price of BioPlus Acquisition Corp. (BIOS) now
50/200 Day Moving Average: $10.47 / $10.26
This figure corresponds to the Average Price over the previous 50/200 days. For BioPlus Acquisition stocks, the 50-day moving average is the support level today.
For BioPlus Acquisition stocks, the 200-day moving average is the support level today.
Are you interested in BioPlus Acquisition Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioPlus Acquisition stock price in 2023, 2024, 2025, 2026, 2027. How much will one BioPlus Acquisition share be worth in 2023 - 2027?
When should I take profit in BioPlus Acquisition stock? When should I record a loss on BioPlus Acquisition stock? What are analysts' forecasts for BioPlus Acquisition stock? What is the future of BioPlus Acquisition stock? We forecast BioPlus Acquisition stock performance using neural networks based on historical data on BioPlus Acquisition stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BioPlus Acquisition stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioPlus Acquisition shares. This happens once a day.
Historical and forecast chart of BioPlus Acquisition stock
The chart below shows the historical price of BioPlus Acquisition stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioPlus Acquisition stock price can be found in the table below.
Long-term forecasts by years.
BioPlus Acquisition daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun 10 | 10.45 | 10.32 | 10.66 | 3.35 |
| Jun 11 | 10.58 | 10.48 | 10.68 | 1.96 |
| Jun 12 | 10.23 | 10.07 | 10.31 | 2.43 |
| Jun 13 | 10.23 | 10.09 | 10.44 | 3.43 |
| Jun 14 | 10.26 | 10.00 | 10.54 | 5.34 |
| Jun 15 | 10.62 | 10.30 | 10.86 | 5.41 |
| Jun 16 | 10.45 | 10.23 | 10.63 | 3.96 |
| Jun 17 | 10.52 | 10.24 | 10.70 | 4.41 |
| Jun 18 | 10.56 | 10.46 | 10.83 | 3.49 |
| Jun 19 | 10.49 | 10.22 | 10.64 | 4.14 |
| Jun 20 | 10.42 | 10.29 | 10.52 | 2.19 |
| Jun 21 | 10.57 | 10.28 | 10.78 | 4.88 |
| Jun 22 | 10.59 | 10.33 | 10.68 | 3.43 |
| Jun 23 | 10.73 | 10.47 | 11.00 | 5.10 |
| Jun 24 | 10.85 | 10.55 | 11.08 | 5.04 |
| Jun 25 | 10.87 | 10.71 | 10.97 | 2.35 |
| Jun 26 | 10.98 | 10.80 | 11.30 | 4.64 |
| Jun 27 | 11.39 | 11.18 | 11.50 | 2.86 |
| Jun 28 | 11.14 | 11.03 | 11.40 | 3.42 |
| Jun 29 | 11.18 | 11.10 | 11.43 | 3.02 |
| Jun 30 | 11.24 | 11.08 | 11.42 | 3.04 |
| Jul 01 | 10.93 | 10.69 | 11.03 | 3.18 |
| Jul 02 | 10.86 | 10.58 | 11.00 | 3.94 |
| Jul 03 | 10.65 | 10.52 | 10.92 | 3.81 |
| Jul 04 | 11.04 | 10.77 | 11.19 | 3.98 |
| Jul 05 | 11.45 | 11.27 | 11.64 | 3.24 |
| Jul 06 | 11.56 | 11.29 | 11.78 | 4.40 |
| Jul 07 | 11.34 | 11.01 | 11.62 | 5.52 |
| Jul 08 | 11.10 | 10.98 | 11.35 | 3.34 |
| Jul 09 | 11.29 | 11.12 | 11.51 | 3.47 |
BioPlus Acquisition Daily Price Targets
BioPlus Acquisition Stock Forecast 06-10-2023.
Forecast target price for 06-10-2023: $10.45.
Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.239%.
Pessimistic target level: 10.32
Optimistic target level: 10.66
BioPlus Acquisition Stock Forecast 06-11-2023.
Forecast target price for 06-11-2023: $10.58.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 1.920%.
Pessimistic target level: 10.48
Optimistic target level: 10.68
BioPlus Acquisition Stock Forecast 06-12-2023.
Forecast target price for 06-12-2023: $10.23.
Negative dynamics for BioPlus Acquisition shares will prevail with possible volatility of 2.374%.
Pessimistic target level: 10.07
Optimistic target level: 10.31
BioPlus Acquisition Stock Forecast 06-13-2023.
Forecast target price for 06-13-2023: $10.23.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 3.314%.
Pessimistic target level: 10.09
Optimistic target level: 10.44
BioPlus Acquisition Stock Forecast 06-14-2023.
Forecast target price for 06-14-2023: $10.26.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 5.069%.
Pessimistic target level: 10.00
Optimistic target level: 10.54
BioPlus Acquisition Stock Forecast 06-15-2023.
Forecast target price for 06-15-2023: $10.62.
Positive dynamics for BioPlus Acquisition shares will prevail with possible volatility of 5.130%.
Pessimistic target level: 10.30
Optimistic target level: 10.86
BIOS (BIOS) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 11.15 | 10.67 | 11.95 | 10.73 |
| Aug. | 11.90 | 11.15 | 12.24 | 8.94 |
| Sep. | 12.07 | 11.62 | 12.32 | 5.68 |
| Oct. | 12.00 | 11.46 | 12.89 | 11.08 |
| Nov. | 11.10 | 10.75 | 11.66 | 7.81 |
| Dec. | 11.82 | 10.92 | 12.36 | 11.66 |
BioPlus Acquisition forecast for this year
BioPlus Acquisition Stock Prediction for Jul 2023
An uptrend is forecast for this month with an optimal target price of $11.1514. Pessimistic: $10.67. Optimistic: $11.95
BioPlus Acquisition Stock Prediction for Aug 2023
An uptrend is forecast for this month with an optimal target price of $11.8986. Pessimistic: $11.15. Optimistic: $12.24
BioPlus Acquisition Stock Prediction for Sep 2023
An uptrend is forecast for this month with an optimal target price of $12.0652. Pessimistic: $11.62. Optimistic: $12.32
BioPlus Acquisition Stock Prediction for Oct 2023
An downtrend is forecast for this month with an optimal target price of $12.0048. Pessimistic: $11.46. Optimistic: $12.89
BioPlus Acquisition Stock Prediction for Nov 2023
An downtrend is forecast for this month with an optimal target price of $11.1045. Pessimistic: $10.75. Optimistic: $11.66
BioPlus Acquisition Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $11.8151. Pessimistic: $10.92. Optimistic: $12.36
BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 11.74 | 11.46 | 12.63 | 9.21 |
| Feb | 11.65 | 11.36 | 12.36 | 8.11 |
| Mar | 11.85 | 11.55 | 12.19 | 5.25 |
| Apr | 12.55 | 12.23 | 13.16 | 7.05 |
| May | 12.86 | 12.39 | 13.17 | 5.96 |
| Jun | 11.91 | 11.27 | 12.62 | 10.75 |
| Jul | 12.12 | 11.31 | 12.48 | 9.33 |
| Aug | 11.89 | 11.44 | 12.50 | 8.47 |
| Sep | 12.87 | 12.43 | 13.53 | 8.09 |
| Oct | 12.59 | 11.88 | 13.21 | 10.09 |
| Nov | 13.40 | 12.34 | 14.26 | 13.44 |
| Dec | 14.22 | 13.48 | 14.55 | 7.33 |
BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 14.45 | 13.94 | 15.10 | 7.66 |
| Feb | 14.71 | 14.14 | 15.78 | 10.44 |
| Mar | 15.18 | 14.10 | 15.54 | 9.28 |
| Apr | 15.73 | 15.35 | 16.69 | 8.01 |
| May | 15.21 | 14.25 | 15.83 | 9.99 |
| Jun | 16.20 | 15.26 | 16.94 | 9.94 |
| Jul | 16.50 | 15.36 | 17.54 | 12.42 |
| Aug | 16.42 | 16.03 | 16.95 | 5.43 |
| Sep | 15.98 | 15.35 | 17.08 | 10.10 |
| Oct | 14.44 | 13.59 | 14.83 | 8.37 |
| Nov | 14.50 | 13.85 | 15.30 | 9.48 |
| Dec | 13.53 | 13.23 | 14.11 | 6.23 |
BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 13.77 | 12.81 | 14.60 | 12.26 |
| Feb | 13.36 | 12.88 | 14.43 | 10.74 |
| Mar | 14.47 | 13.40 | 15.54 | 13.78 |
| Apr | 14.71 | 13.79 | 15.04 | 8.32 |
| May | 15.26 | 14.95 | 16.31 | 8.33 |
| Jun | 16.19 | 15.15 | 16.85 | 10.09 |
| Jul | 15.43 | 14.58 | 16.43 | 11.27 |
| Aug | 15.44 | 14.22 | 15.89 | 10.50 |
| Sep | 16.29 | 15.40 | 16.75 | 8.07 |
| Oct | 15.06 | 13.99 | 16.00 | 12.61 |
| Nov | 14.47 | 13.92 | 15.60 | 10.76 |
| Dec | 14.03 | 13.29 | 14.60 | 8.94 |
BioPlus Acquisition (BIOS) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 13.42 | 12.77 | 13.90 | 8.11 |
| Feb | 12.85 | 11.83 | 13.30 | 11.11 |
| Mar | 12.76 | 12.34 | 13.03 | 5.29 |
| Apr | 12.58 | 11.62 | 12.94 | 10.21 |
| May | 12.64 | 12.23 | 13.56 | 9.79 |
| Jun | 12.91 | 11.94 | 13.35 | 10.54 |
| Jul | 13.40 | 12.55 | 13.75 | 8.77 |
| Aug | 13.59 | 13.24 | 14.33 | 7.59 |
| Sep | 13.01 | 12.14 | 13.70 | 11.40 |
| Oct | 13.45 | 12.87 | 14.08 | 8.60 |
| Nov | 12.92 | 12.14 | 13.42 | 9.54 |
| Dec | 12.07 | 11.70 | 12.49 | 6.38 |
BioPlus Acquisition information and performance
BioPlus Acquisition Corp. operates as a blank check company. It is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 11, 2021 and is headquartered in New York, NY.
260 MADISON AVENUE, SUITE 800, NEW YORK, NY, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
